Guardant Health plans $500M convertible notes offering due 2032
Guardant Health intends to sell $500M of convertible senior notes maturing in 2032. Interest rate and conversion terms will be set at pricing.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Guardant Health, as reported by TradingView, said it intends to offer $500M of convertible senior notes maturing May 15, 2032. The offering will be a private placement to qualified institutional buyers. Initial purchasers have an option to buy up to $50M more within 13 days of the notes being issued.
The company expects to use part of the proceeds to repurchase some of its 0% convertible notes due 2027 and to fund capped call transactions aimed at reducing dilution. The interest rate and initial conversion rate will be set at pricing. Remaining proceeds would go to general corporate purposes. The company stresses that the offering depends on market conditions and may not be completed.
why it matters
For shareholders, a convertible issue carries dilution risk, though the capped calls are meant to offset part of it. Hedging by banks and investors in the stock could move GH shares temporarily. For the broader market, this is a mid-sized debt refinancing by one company.
tags
instruments
sources
- Guardant Health (GH) Proposes $500M Convertible Notes Offering Due 2032 — TradingView, 11 November 2026 at 21:17 UTC
- Guardant Health Announces Proposed $500.0 Million Offering of Convertible Senior Notes Due 2032 — TradingView, 11 November 2026 at 21:17 UTC
- Guardant Health Announces Proposed $500.0 Million Offering Of Convertible Senior Notes Due 2032 — Reuters, 11 November 2026 at 21:48 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗